Skip to main content
. 2021 Jan 12;11:745. doi: 10.1038/s41598-020-80497-6

Figure 5.

Figure 5

VEGFR2 inhibition causes regression of human blood vessels. (a) Schema for tumor transplantation into the cranial window and ramucirumab or isotype IgG treatment. b-d, VEGFR2 inhibition decreases human blood vessels. Representative images of huCD31-AF488-positive human blood vessels (huCD31, green) (b). Quantification of total human blood vessel length (c) and relative length (d) after ramucirumab (Ram) or isotype IgG (Isotype) treatment. (eg): Transplanted tissues were sectioned for the analysis of human and mouse blood vessels. Representative images for the expression of human CD31 (huCD31, green), mouse CD31 (moCD31, red), and/or human nuclei (HuNu, blue) (e). Quantification of the total length of human (f) and mouse (g) blood vessels. Data are mean ± SD. (isotype IgG: n = 5, ramucirumab: n = 4). Welch´s t test was used to compare with isotype IgG-treated mice. *: p < 0.05. **: p < 0.01. n.s.: not significant.